Sudan Loganathan Profile - Stephens Analyst

18 Followers
tipranks
Sudan Loganathan

Sudan Loganathan
Stephens

Wall Street Analyst
#3,966 out of 10,123 Wall Street Analysts
#10,359 out of 42,330 experts

Success Rate

52%
13 out of 25 ratings made a profit

Average Return

+8.50%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Sudan Loganathan's trades since 2024 and holding each position for 1 Year would result in 52.00% of your transactions generating a profit, with an average return of 8.5% per rating.

Stock Rating Distribution

34Ratings
76.47% Buy
23.53% Hold
0.00% Sell
Distribution of Sudan Loganathan's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States
Canada

Best Rating

Stock:
Delcath Systems, Inc.
(DCTH)
Rating:Buy
Date:May 13, 2024 - May 13, 2025
Return:+183.10%
The most profitable rating made by Sudan Loganathan

Sudan Loganathan's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Delcath Systems
May 13, 2024
Buy
Assigned
$25.00
(190.36% Upside)
1Ratings
100%
+183.10%
Bicycle Therapeutics
Nov 07, 2024
Hold
Initiated
$25.00
(287.00% Upside)
1Ratings
0.00%
Pyxis Oncology
Nov 07, 2024
Buy
Initiated
$13.00
(179.57% Upside)
1Ratings
0%
-0.70%
Fennec Pharmaceuticals
Nov 18, 2024
Buy
Initiated
C$21.05
(69.04% Upside)
1Ratings
100%
+90.50%
IDEAYA Biosciences
Nov 18, 2024
Buy
Initiated
$51.00
(52.97% Upside)
1Ratings
100%
+21.40%
Kymera Therapeutics
Nov 18, 2024
Buy
Initiated
$65.00
(1.40% Upside)
1Ratings
100%
+50.00%
Actinium Pharmaceuticals
Nov 19, 2024
Buy
Reiterated
$5.00
(244.83% Upside)
2Ratings
0%
-47.35%
ADC Therapeutics
Feb 24, 2025
Buy
Reiterated
$8.00
(101.51% Upside)
2Ratings
100%
+95.45%
Catalyst Pharma
Feb 28, 2025
Buy
Reiterated
$40.00
(77.30% Upside)
2Ratings
100%
+5.50%
ELEV
Elevation Oncology
Mar 24, 2025
Hold
Downgraded
$1.00
(173.97% Upside)
2Ratings
0%
-91.80%
List of latest recommendations made by Sudan Loganathan. Click to expand and see Sudan Loganathan's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Sudan Loganathan activity FAQ

What is the performance of Sudan Loganathan's recommendations?
The percentage of profitable recommendations made by Sudan Loganathan is 52%, and the average return per transaction is 8.50%.
    What stocks does Sudan Loganathan cover?
    Sudan Loganathan mostly covers EXEL ,ARVN ,IMNM stocks.
      What was Sudan Loganathan's most profitable rating?
      Sudan Loganathan’s most profitable ratings was a buy on DCTH stock on May 13, 2024 - May 13, 2025. The return on the trade was +183.10%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here